NEW YORK (GenomeWeb) – InSource Diagnostics, a CLIA-certified clinical laboratory that performs blood, urine, and saliva testing, is enrolling patients in a clinical trial designed to validate biomarkers in urine that screen for patients who would likely benefit from DNA tests and could then receive more precise and beneficial drug prescriptions.

The biomarkers, measured in a routine urine test, would provide a more targeted approach for physicians selecting people within a patient population who could benefit from genetic testing.